We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
National Bank Holdings
NBHC
$1.9B
| $16M | 0.01% |
453,019
+800
| +0.2% | +$28.2K |
|
|
BOLD
1302
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16M | 0.01% |
266,586
-149,316
| -36% | -$5.6M |
|
|
CORE
1303
DELISTED
Core Mark Holding Co., Inc.
CORE
| $15.9M | 0.01% |
586,321
+65,061
| +12% | +$1.8M |
|
1304
Range Resources
RRC
$8.95B
| $15.9M | 0.01% |
3,286,353
-195,306
| -6% | -$788K |
|
1305
Extreme Networks
EXTR
$3.15B
| $15.9M | 0.01% |
2,156,397
-53,261
| -2% | -$373K |
|
|
MRTX
1306
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.9M | 0.01% |
123,195
-900
| -0.7% | -$86.8K |
|
|
CVGW
1307
DELISTED
Calavo Growers
CVGW
| $15.9M | 0.01% |
175,120
-4,474
| -2% | -$400K |
|
1308
Caesars Entertainment
CZR
$6.14B
| $15.9M | 0.01% |
265,807
-4,142
| -2% | -$205K |
|
1309
Sonoco
SON
$5.74B
| $15.7M | 0.01% |
253,995
-10,776
| -4% | -$637K |
|
1310
Integra LifeSciences
IART
$1.34B
| $15.7M | 0.01% |
268,846
+5,410
| +2% | +$322K |
|
1311
Stride
LRN
$3.43B
| $15.6M | 0.01% |
768,607
-23,000
| -3% | -$491K |
|
1312
SiteOne Landscape Supply
SITE
$4.53B
| $15.6M | 0.01% |
172,393
-3,405
| -2% | -$289K |
|
1313
Q2 Holdings
QTWO
$3.92B
| $15.6M | 0.01% |
192,655
-2,088
| -1% | -$160K |
|
1314
United Bankshares
UBSI
$6.62B
| $15.6M | 0.01% |
403,556
-7,663
| -2% | -$296K |
|
1315
MillerKnoll
MLKN
$1.67B
| $15.6M | 0.01% |
374,416
+41,249
| +12% | +$1.91M |
|
|
GLDD
1316
DELISTED
Great Lakes Dredge & Dock
GLDD
| $15.6M | 0.01% |
1,376,325
-38,278
| -3% | -$409K |
|
1317
Qualys
QLYS
$6.35B
| $15.6M | 0.01% |
186,722
-1,486
| -0.8% | -$123K |
|
1318
V2X
VVX
$2.65B
| $15.6M | 0.01% |
303,424
+3,489
| +1% | +$168K |
|
1319
Albany International
AIN
$1.78B
| $15.5M | 0.01% |
203,812
-150,950
| -43% | -$12.5M |
|
|
FL
1320
DELISTED
Foot Locker
FL
| $15.5M | 0.01% |
396,731
+3,790
| +1% | +$160K |
|
1321
Erie Indemnity
ERIE
$13.2B
| $15.5M | 0.01% |
93,182
-31,459
| -25% | -$5.55M |
|
|
CCXI
1322
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.5M | 0.01% |
390,853
+139,893
| +56% | +$2.46M |
|
1323
Commerce Bancshares
CBSH
$8.5B
| $15.4M | 0.01% |
304,383
-23,328
| -7% | -$1.09M |
|
1324
Veracyte
VCYT
$3.8B
| $15.4M | 0.01% |
551,405
-572,661
| -51% | -$14.8M |
|
1325
PennyMac Financial
PFSI
$4.02B
| $15.4M | 0.01% |
452,042
-5
| -0% | -$162 |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.